Nanomedicine News

RSS
Nanotechnology Drug in Droplets for Painless Treatment of Secondary Blindness

Nanotechnology Drug in Droplets for Painless Treatment of Secondary Blindness

Encapsulated, Nanobody-Targeted Drugs Cold Help Treat Sleeping Sickness

Encapsulated, Nanobody-Targeted Drugs Cold Help Treat Sleeping Sickness

Research on New Means to Kill Harmful Bacteria Published in Nano Letters

Research on New Means to Kill Harmful Bacteria Published in Nano Letters

Multifunctional Nanohybrid Materials Can Play an Important Role in Noninvasive Cancer Diagnosis

Multifunctional Nanohybrid Materials Can Play an Important Role in Noninvasive Cancer Diagnosis

Nanometric Sensor Identifies Biomarkers of Cancer, Nervous System Diseases

Nanometric Sensor Identifies Biomarkers of Cancer, Nervous System Diseases

FDA Authorizes Clinical Trials for AstraZeneca’s Accurin AZD2811 Developed Using Bind Nanomedicine Platform

FDA Authorizes Clinical Trials for AstraZeneca’s Accurin AZD2811 Developed Using Bind Nanomedicine Platform

New Wirelessly Controlled Nanowire Implantable Drug-Delivery System

New Wirelessly Controlled Nanowire Implantable Drug-Delivery System

Nano-Packaged Drug Can Halt and Reverse Progression of Atherosclerosis in Rodents

Nano-Packaged Drug Can Halt and Reverse Progression of Atherosclerosis in Rodents

Scientists Generate 5nm Gold Nanoparticles Radioactively Labeled with Gold Isotope

Scientists Generate 5nm Gold Nanoparticles Radioactively Labeled with Gold Isotope

Cour's COUR-NP-GLI Bioengineered Nanoparticles Tested in Animal Model of Celiac Disease

Cour's COUR-NP-GLI Bioengineered Nanoparticles Tested in Animal Model of Celiac Disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.